Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Hazard Mater ; 467: 133659, 2024 Apr 05.
Artigo em Inglês | MEDLINE | ID: mdl-38350314

RESUMO

Arsenic is a harmful associated element in antimony ore, which might bring out the risk of leakage during complex industrial production of high-purity antimony. Herein, we reported a novel and efficient way to remove the trace arsenic impurity from acidic SbCl3 solution by utilizing copper-system bimetallic particles. Specifically, galvanically coupled Cu2Sb/Cu was in-situ synthesized by introducing precursor copper powder to the specific SbCl3 solution. DFT studies revealed that Sb(III) was easily reduced by Cu to form Cu2Sb due to the strong adsorption of Sb(III) on Cu (111) crystal plane. The Cu2Sb/Cu coupling exhibited excellent activity for As(III) reduction, over 99.4% arsenic were removed under optimal conditions and residual arsenic concentration dropped to only 2.7 mg L-1. Crucially, Sb(III) concentration changes could be neglected. Besides, the dearsenization residues were extensively characterized to analyze the evolvement and cause in the reaction process. The results confirmed that the arsenic removal mechanisms by Cu2Sb/Cu particles were multi-affected, including adsorption, displacement, and precipitation. And the strong electrostatic attraction of AsO+ under high HCl conditions was identified as a key step to achieving dearsenization. This research will provide a theoretical guidance for the green synthesis of high-purity antimony and related products.

2.
Nutr Rev ; 81(8): 939-950, 2023 07 10.
Artigo em Inglês | MEDLINE | ID: mdl-36860183

RESUMO

CONTEXT: The relationship between food restriction (FR) and liver enzyme levels, such as alanine transferase (ALT), aspartate transferase (AST), and γ-glutamyl transferase (GGT), has not yet been confirmed. OBJECTIVE: A meta-analysis of research articles was conducted to investigate the association of FR and liver enzyme levels. DATA SOURCES: The PubMed, Web of Science, Embase, and Cochrane Library databases were screened for articles published up to April 30, 2022. DATA EXTRACTION: Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement methodology was used to search for research articles. Publication bias was detected using Begg's test. Finally, 17 trials involving 1982 participants and that reported mean value, mean difference, and standard deviation were identified. DATA ANALYSIS: Data were described as the weighted mean difference of body mass index, body weight, and standardized mean difference (SMD) of ALT, AST, and GGT. A reduction in ALT level was observed after a FR intervention (total SMD, -0.36, 95% confidence interval [CI], -0.68 to -0.05). GGT levels also were decreased in 4 studies (total SMD, -0.23; 95%CI, -0.33 to -0.14). According to subgroup analysis, serum AST levels decreased in the medium-term (between 5 wk and 6 mo) group (subtotal SMD, -0.48; 95%CI, -0.69 to -0.28). CONCLUSION: Existing evidence suggests that dietary restriction improves adult liver enzyme levels. The long-term maintenance of healthy liver enzyme levels, particularly in real-world applications, necessitates additional consideration.


Assuntos
Alimentos , Fígado , gama-Glutamiltransferase , Adulto , Humanos , Índice de Massa Corporal , Peso Corporal
3.
Molecules ; 28(4)2023 Feb 10.
Artigo em Inglês | MEDLINE | ID: mdl-36838686

RESUMO

Atherosclerosis (AS) is a common cardiovascular disease and remains the leading cause of death in the world. It is generally believed that the deposition of foam cells in the arterial wall is the main cause of AS. Moreover, promoting cholesterol efflux and enhancing the ability of reverse cholesterol transport (RCT) can effectively inhibit the formation of foam cells, thereby preventing the occurrence and development of AS. Astaxanthin, with a powerful antioxidant ability, has a potential role in the prevention of atherosclerosis, but how it works in preventing atherosclerosis remains unknown. Here, our experimental results suggest that astaxanthin can upregulate the expression of circular RNA tripeptidyl-peptidase II (circTPP2) and eventually promote cholesterol efflux by modulating ATP-binding cassette subfamily A member 1 (ABCA1). The expression of ABCA1 was significantly suppressed after knocking down circTPP2 in macrophage-derived foam cells. In addition, the experimental results showed that circTPP2 could downregulate the expression of microRNA-3073b-5p (miR-3073b-5p), and ABCA1 was identified as the target gene of miR-3073b-5p. In conclusion, the circTPP2/miR-3073b-5p/ABCA1 axis may be the specific mechanism of astaxanthin promoting cholesterol efflux.


Assuntos
Aterosclerose , MicroRNAs , Animais , Camundongos , Células Espumosas/metabolismo , MicroRNAs/genética , Colesterol/metabolismo , Células RAW 264.7 , Aterosclerose/metabolismo , LDL-Colesterol/metabolismo , Transportador 1 de Cassete de Ligação de ATP/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...